One year in review 2016: novelties in the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental rheumatology 2016-05, Vol.34 (3), p.357-372
Main Authors: Calabrò, Andrea, Caterino, Anna Laura, Elefante, Elena, Valentini, Valentina, Vitale, Antonio, Talarico, Rosaria, Cantarini, Luca, Frediani, Bruno
Format: Article
Language:English
Subjects:
Antirheumatic Agents - pharmacology
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - immunology
Arthritis, Rheumatoid - physiopathology
Arthritis, Rheumatoid - psychology
Biological Therapy - methods
Clinical Trials as Topic
Humans
Medication Therapy Management - trends
Patient Selection
Quality of Life
Therapies, Investigational
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.
ISSN:0392-856X